Diversify Wealth Management LLC Acquires Shares of 56,060 Kenvue Inc. $KVUE

Diversify Wealth Management LLC acquired a new stake in Kenvue Inc. (NYSE:KVUE) in the first quarter, HoldingsChannel.com reports. The firm acquired 56,060 shares of the company’s stock, valued at approximately $966,000.

A number of other large investors have also recently bought and sold shares of the business. Citizens Financial Group Inc. RI acquired a new position in Kenvue in the 1st quarter valued at about $242,000. Fifth Third Bancorp raised its position in Kenvue by 167.3% during the 1st quarter. Fifth Third Bancorp now owns 602,532 shares of the company’s stock worth $10,388,000 after buying an additional 377,133 shares during the last quarter. Simplicity Wealth LLC lifted its stake in shares of Kenvue by 88.2% in the 1st quarter. Simplicity Wealth LLC now owns 40,557 shares of the company’s stock worth $699,000 after acquiring an additional 19,006 shares during the period. Candriam S.C.A. boosted its holdings in shares of Kenvue by 5.0% in the first quarter. Candriam S.C.A. now owns 134,736 shares of the company’s stock valued at $2,323,000 after acquiring an additional 6,356 shares in the last quarter. Finally, Sequoia Financial Advisors LLC lifted its position in Kenvue by 13.9% in the first quarter. Sequoia Financial Advisors LLC now owns 72,458 shares of the company’s stock valued at $1,249,000 after purchasing an additional 8,838 shares during the period. Institutional investors and hedge funds own 97.64% of the company’s stock.

Kenvue Stock Down 0.3%

Kenvue stock opened at $18.70 on Thursday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.70 and a current ratio of 0.98. The stock’s fifty day moving average is $18.14 and its two-hundred day moving average is $17.83. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $22.87. The firm has a market capitalization of $35.89 billion, a price-to-earnings ratio of 21.99, a price-to-earnings-growth ratio of 1.42 and a beta of 0.47.

Kenvue (NYSE:KVUE) last announced its quarterly earnings results on Thursday, May 7th. The company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.27 by $0.05. The company had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $3.84 billion. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. The company’s revenue for the quarter was up 4.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.24 earnings per share. Analysts predict that Kenvue Inc. will post 1.16 EPS for the current fiscal year.

Kenvue Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 27th. Investors of record on Wednesday, May 13th were given a dividend of $0.2075 per share. This represents a $0.83 annualized dividend and a dividend yield of 4.4%. The ex-dividend date was Wednesday, May 13th. Kenvue’s payout ratio is currently 97.65%.

Analysts Set New Price Targets

Several research firms have issued reports on KVUE. Weiss Ratings upgraded Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, June 15th. Barclays decreased their price target on Kenvue from $19.00 to $18.00 and set an “equal weight” rating on the stock in a research note on Tuesday, April 14th. Citigroup dropped their price objective on Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. UBS Group cut their price objective on Kenvue from $19.00 to $18.00 and set a “neutral” rating for the company in a research report on Tuesday, April 7th. Finally, Wall Street Zen raised Kenvue to a “buy” rating in a report on Sunday. Three equities research analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $19.33.

Insider Transactions at Kenvue

In related news, General Counsel Matthew Orlando sold 38,491 shares of the company’s stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $17.66, for a total value of $679,751.06. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 1.59% of the company’s stock.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.